Maternal obesity induces chronic inflammatory responses that impact the fetus/neonate during the perinatal period. Inflammation, iron regulation, and myelination are closely interconnected and disruptions in these processes may have deleterious effects on neurodevelopment. Hepcidin levels are increased in response to inflammation causing subsequent decreases in ferroportin and available iron needed for myelination. Our current studies were designed to test the hypotheses that: 1) maternal high fat diet (HFD) prior to and during pregnancy is sufficient to induce inflammation and alter iron regulation in the brain of the offspring, and 2) HFD exposure is associated with altered myelination and neurobehavioral deficits in the offspring. Our data revealed modest increases in inflammatory cytokines in the serum of dams fed HFD prior to pregnancy compared to dams fed a control diet (CD). Early increases in IL-5 and decreases in IL-10 were observed in serum at PN7 while IL-5 remained elevated at PN21 in the HFDexposed pups. At PN0, most cytokine levels in whole brain homogenates were higher in the pups born to HFD-fed dams but were not different or were lower than in pups born to CD-fed dams at PN21. Conversely, the inflammation mediated transcription factor Nurr77 remained elevated at PN21. At birth, brain hepcidin, ferroportin, and L-ferritin levels were elevated in pups born to HFD-fed dams compared to pups born to CD-fed dams. Hepcidin levels remained elevated at PN7 and PN21 while ferroportin and Lferritin levels were lower at PN7 and were not different at PN21. Decreases in myelination in the medial cortex were observed in male but not in female pups born to maternal HFD-fed dams at PN21. These structural changes correlated with changes in behavior (novel object recognition) in at 4 months in males only. Our data indicate that maternal obesity (HFD) results in disruption of iron regulation in the brains of the offspring with structural and neurobehavioral deficits in males.
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Introduction
Pre-pregnancy maternal obesity is a worldwide problem affecting approximately one third of women of childbearing age in the United States (Ogden et al., 2013) . Maternal obesity confers significant maternal and fetal/neonatal health risks during the perinatal period including preeclampsia/gestational hypertension, gestational diabetes mellitus (Scott-Pillai et al., 2013) , preterm delivery (Cnattingius et al., 2013; Khatibi et al., 2012) , stillbirth (Salihu, 2011; Yao et al., 2014) , and delivery complications such as need for cesarean section or shoulder dystocia (Magann et al., 2013; Ruager-Martin et al., 2010; Scott-Pillai et al., 2013; Stothard et al., 2009; Turcksin et al., 2014) . Infants born to obese mothers are also at an increased risk for long-term health problems including obesity and metabolic syndrome (Boney et al., 2005) . More recent research indicates that children born to obese mothers are also at an increased risk for impaired neurodevelopment and http://dx.doi.org/10.1016/j.bbi.2016.08.005 0889-1591/Ó 2016 Elsevier Inc. All rights reserved.
Abbreviations: HFD, high fat diet; CD, control purified diet; DIO, diet induced obesity; PFA, paraformaldehyde; PBS, phosphate buffered saline; SEM, standard error of the mean.
